Skip to main content

Table 1 General characteristics of cases and population-based controls

From: Risk factors for severe COVID-19 in the young—before and after ICU admission

 

Cases

Controls

Number (n)

4921

49 210

Age (mean (SD))

62.45 (13.00)

62.45 (13.00)

Age group (%)

 Less than 50

817 (16.6)

8580 (17.4)

 Between 50 and 64

1797 (36.5)

18 120 (36.8)

 More than 65

2307 (46.9)

22 510 (45.7)

 Sex (women (%))

1447 (29.4)

14 470 (29.4)

Income category (%)

 1

2146 (43.7)

15 863 (32.3)

 2

1526 (31.1)

16 483 (33.6)

 3

1237 (25.2)

16 772 (34.1)

Education (%)

 Primary

1385 (29.1)

10 216 (21.1)

 Secondary

2141 (45.0)

22 023 (45.5)

 Post-secondary

1236 (26.0)

16 196 (33.4)

Region of birth (%)

 Africa

213 (4.3)

1199 (2.4)

 Asia

861 (17.5)

4286 (8.7)

 EU15, excl. Nordic

98 (2.0)

842 (1.7)

 Europa, excl. EU15 and Nordic

436 (8.9)

3250 (6.6)

 North America

19 (0.4)

176 (0.4)

 Nordic countries, excl. Sweden

202 (4.1)

1669 (3.4)

 Oceania

1 (0.0)

11 (0.0)

 Unknown

5 (0.0)

8 (0.0)

 Soviet Union

3 (0.1)

50 (0.1)

 Sweden

2 989 (60.7)

37 224 (75.6)

 South America

94 (1.9)

495 (1.0)

Pre-existing diagnoses (%)

 Hypertension

1753 (35.6)

11 524 (23.4)

 Kidney disease

242 (4.9)

781 (1.6)

 Rheumatoid arthritis

132 (2.7)

604 (1.2)

 Systemic inflammatory disease

136 (2.8)

718 (1.5)

 Inflammatory bowel disease

81 (1.6)

658 (1.3)

 Venous thromboembolism

270 (5.5)

1570 (3.2)

 Obesity

529 (10.7)

1770 (3.6)

 Chronic obstructive pulmonary disease

231 (4.7)

1273 (2.6)

 Myocardial infarction

275 (5.6)

1871 (3.8)

 Heart failure

296 (6.0)

1635 (3.3)

 Atrial fibrillation

426 (8.7)

3222 (6.5)

 Type 1 diabetes

202 (4.1)

964 (2.0)

 Asthma

388 (7.9)

1799 (3.7)

 Type 2 diabetes

948 (19.3)

4223 (8.6)

 Angina

284 (5.8)

1973 (4.0)

 Malignancy

431 (8.8)

4142 (8.4)